StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) income statement

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics Inc. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
4.16
Debt to equity
–
Debt to assets
–
Cash to current liabilities
378.7%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?